Literature DB >> 17888893

BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B cell cultures.

Timothy H Caven1, Jamie L Sturgill, Daniel H Conrad.   

Abstract

We sought to discover the mechanisms explaining increased IgE production seen at low cell densities when IL-21 is added to human B cell cultures activated with anti-CD40 and IL-4. When cells were cultured in the absence of BCR ligation, qPCR demonstrated dramatic increases in mRNA for the plasma cell transcription factors BLIMP1 and XBP1. Furthermore, a majority of viable cells expressed high levels of CD38 while losing expression of surface IgD. In contrast, in the presence of BCR stimulation, both the XBP1 mRNA levels and CD38 cell surface expression were markedly reduced, and a large population of cells retained IgD expression, indicating reduced plasma cell differentiation. IgE levels were reduced in the BCR stimulated cultures by 90%, while IgG4 levels remained unchanged. In summary, IL-21 enhances IgE production at low densities through stimulating cell division and plasma cell differentiation and this activity is reduced upon BCR cross-linking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888893      PMCID: PMC2075084          DOI: 10.1016/j.cellimm.2007.07.007

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  22 in total

Review 1.  The global burden of asthma: executive summary of the GINA Dissemination Committee report.

Authors:  Matthew Masoli; Denise Fabian; Shaun Holt; Richard Beasley
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

2.  Isotype switching by human B cells is division-associated and regulated by cytokines.

Authors:  Stuart G Tangye; Anthea Ferguson; Danielle T Avery; Cindy S Ma; Philip D Hodgkin
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.

Authors:  J Parrish-Novak; S R Dillon; A Nelson; A Hammond; C Sprecher; J A Gross; J Johnston; K Madden; W Xu; J West; S Schrader; S Burkhead; M Heipel; C Brandt; J L Kuijper; J Kramer; D Conklin; S R Presnell; J Berry; F Shiota; S Bort; K Hambly; S Mudri; C Clegg; M Moore; F J Grant; C Lofton-Day; T Gilbert; F Rayond; A Ching; L Yao; D Smith; P Webster; T Whitmore; M Maurer; K Kaushansky; R D Holly; D Foster
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 4.  Advances in upper airway diseases and allergen immunotherapy.

Authors:  Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

5.  Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells.

Authors:  Jérôme Pène; Jean-François Gauchat; Sandrine Lécart; Elodie Drouet; Paul Guglielmi; Vera Boulay; Adriana Delwail; Don Foster; Jean-Claude Lecron; Hans Yssel
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

7.  A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells.

Authors:  Stuart G Tangye; Danielle T Avery; Philip D Hodgkin
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells.

Authors:  Akira Suto; Hiroshi Nakajima; Koichi Hirose; Kotaro Suzuki; Shin-ichiro Kagami; Yohei Seto; Aihiro Hoshimoto; Yasushi Saito; Donald C Foster; Itsuo Iwamoto
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 9.  The biology of IGE and the basis of allergic disease.

Authors:  Hannah J Gould; Brian J Sutton; Andrew J Beavil; Rebecca L Beavil; Natalie McCloskey; Heather A Coker; David Fear; Lyn Smurthwaite
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses.

Authors:  Michishige Harada; Kumiko Magara-Koyanagi; Hiroshi Watarai; Yuko Nagata; Yasuyuki Ishii; Satoshi Kojo; Shigetoshi Horiguchi; Yoshitaka Okamoto; Toshinori Nakayama; Nobutaka Suzuki; Wen-Chen Yeh; Shizuo Akira; Hiroshi Kitamura; Osamu Ohara; Ken-ichiro Seino; Masaru Taniguchi
Journal:  J Exp Med       Date:  2006-12-18       Impact factor: 14.307

View more
  5 in total

1.  Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production.

Authors:  Nina Kim; Sesquile Ramon; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps
Journal:  Eur J Immunol       Date:  2015-11-02       Impact factor: 5.532

2.  Glutamate signaling through the kainate receptor enhances human immunoglobulin production.

Authors:  Jamie L Sturgill; Joel Mathews; Peggy Scherle; Daniel H Conrad
Journal:  J Neuroimmunol       Date:  2011-01-06       Impact factor: 3.478

3.  Role of sphingosine kinase 1 and sphingosine-1-phosphate in CD40 signaling and IgE class switching.

Authors:  Eugene Y Kim; Jamie L Sturgill; Nitai C Hait; Dorit Avni; Evelyn C Valencia; Michael Maceyka; Santiago Lima; Jeremy Allegood; Wei-Ching Huang; Shijun Zhang; Sheldon Milstien; Daniel Conrad; Sarah Spiegel
Journal:  FASEB J       Date:  2014-07-01       Impact factor: 5.191

4.  Jinkui Shenqi Pills Ameliorate Asthma with "Kidney Yang Deficiency" by Enhancing the Function of the Hypothalamic-Pituitary-Adrenal Axis to Regulate T Helper 1/2 Imbalance.

Authors:  Bing Ji; Yuan-Yuan Li; Wei-Ji Yang; Li-Zong Zhang; Ming-Sun Fang; Hui-Ying Fu; Qi-Yang Shou
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-08       Impact factor: 2.629

5.  Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer.

Authors:  Alica Linnebacher; Philipp Mayer; Nicole Marnet; Frank Bergmann; Esther Herpel; Steffie Revia; Libo Yin; Li Liu; Thilo Hackert; Thomas Giese; Ingrid Herr; Matthias M Gaida
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.